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The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
Kidney International (2011) 80, 1000; doi:10.1038/ki.2011.310
Correction to: Kidney International (2011) 80, 17–28; doi:10.1038/ki.2010.483; published online 8 December 2010
For the above-referenced article, Figure 5 did not include bold font numbers to indicate statistical significance of
hazard ratios, as described in the legend. The correct figure is included below.
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For the above-referenced article, there was an error in Figure 4b. The correct figure and caption are shown below.
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Figure 5 | Summary of categorical meta-analysis (adjusted relative risk (RR)) for general population cohorts with albumin-to-
creatinine ratio (ACR). Mortality is reported for general population cohorts assessing albuminuria as urine ACR. Kidney outcomes are
reported for general population cohorts assessing albuminuria as either urine ACR or dipstick. Estimated glomerular filtration rate (eGFR)
and albuminuria are expressed as categorical variables. All results are adjusted for covariates and compared with the reference cell
(Ref). Each cell represents a pooled relative risk from a meta-analysis; bold numbers indicate statistical significance at Po0.05.
Incidence rates per 1000 person-years for the reference cells are 7.0 for all-cause mortality, 4.5 for cardiovascular disease mortality,
0.04 for kidney failure, 0.98 for acute kidney injury (AKI), and 2.02 for kidney disease progression. Absolute risk can be computed by
multiplying the relative risks in each cell by the incidence rate in the reference cell. Colors reflect the ranking of adjusted relative risk.
The point estimates for each cell were ranked from 1 to 28 (the lowest RR having rank number 1, and the highest number 28).
The categories with rank numbers 1–8 are green, rank numbers 9–14 are yellow, the rank numbers 15–21 are orange, and the rank numbers
22–28 are colored red. (For the outcome of kidney disease progression, two cells with RRo1.0 are also green, leaving fewer cells as orange.)
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